Recent research looks at how heart, kidney and metabolic problems can quietly raise the chance of getting cancer. The study followed a huge group of people across the country for many years to see if worse health in these areas meant more cancer. The new idea, called CKM syndrome, shows that the hea
The U. S. Supreme Court will hear Bayer AG’s attempt to stop thousands of lawsuits that say the company did not warn people about Roundup’s cancer risk. Bayer wants federal pesticide rules to block state‑law claims like the one that earned a Missouri jury $1. 25 million for John Durnell, who says gl
A woman named Karyn Paringatai noticed a disturbing trend in her relatives: many died at a young age. When she traced their medical records, she found that a rare stomach cancer, known as diffuse gastric cancer, was common among Māori families like hers. This type of cancer can develop without
A recent study looked at the DNA of people with mouth cancer to find hidden patterns. Researchers used data from many patients, focusing on those whose tumors were not linked to smoking, drinking or HPV infection. They found that the way cancer cells change their DNA depends on where in the mouth th
Scientists are pushing the limits of CAR T-cell therapy, a treatment where a patient’s immune cells get rebuilt to hunt down disease. Right now, it works well against certain blood cancers but struggles with solid tumors and autoimmune conditions. Why? The cells often pick the wrong targets, fail to
The heart never stops. Every second of every day, it pumps blood through miles of vessels, pushing against high pressure to keep the body alive. This relentless mechanical work turns the heart into a tough environment for cancer cells. While cancer spreads easily to organs like the lungs or liver, i
In 2023, seven leading economies made a quiet vow to join forces against some of the toughest cancers. Australia, Canada, France, Germany, Japan, the UK and the US promised to share knowledge and speed up care for cancers where survival rates are often low. The challenge they faced wasn’t just medic
Pancreatic cancer is one of the most lethal cancers in the United States, killing more than 50, 000 people each year. The disease is tough to treat and most patients die within a year of diagnosis, with only a small fraction surviving five years. Recently, two experimental drugs have entered clin
After surgery, patients with advanced esophageal cancer often face the risk of the disease coming back. A recent real‑world study examined how well a drug called nivolumab, given after surgery, can predict who might see the cancer return. The researchers looked at a group of people who had their tum
The link between long‑term gut inflammation and colorectal cancer is clear, but the focus has usually been on DNA changes in the lining cells. Recent research shows that the surrounding support cells, called fibroblasts, play a much bigger part than previously thought. These cells build the structur
